Literature DB >> 15317453

Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor.

Dan T Major1, Victoria Nahum, Yingfei Wang, Georg Reiser, Bilha Fischer.   

Abstract

In the companion paper, part 1, we described the construction of an improved molecular model for the h-P2Y1 receptor (h-P2Y1-R) and proposed a rational for the stereoelectronic selectivity of the receptor. Here, we extend our studies on the molecular recognition of the h-P2Y1-R to the exploration of the diastereoselectivity of this receptor. For this purpose, we implemented an integrative approach combining synthesis, spectral analysis, biochemical assays, and computational analysis. Specifically, we selected and synthesized novel ATP analogues bearing a chiral center on the phosphate chain. We analyzed the conformation of the chiral ATP analogues in solution by 1H/13C NMR and assigned the absolute configuration of the diastereoisomers. The coordination mode of these analogues with a Mg2+ ion was evaluated by 31P NMR. These chiral analogues were biochemically evaluated and found to be potent h-P2Y1-R ligands. An EC50 difference of ca. 20-fold was observed between the diastereoisomers. Their spectral absolute configuration assignment was confirmed by comparison of the biochemical results to those of ATP-alpha-S diastereoisomers whose chirality is known. Finally, a computational analysis was performed for the elucidation of molecular recognition employing molecular mechanics (docking) studies on the receptor:ligands complexes. On the basis of the current results, we hypothesize that h-P2Y1-R's chiral discrimination originates from the requirement that the nucleotide analogue interacts with a Mg2+ ion within the receptor binding site. This Mg2+ ion is possibly coordinated with both Asp204 and the ATP's alpha, beta, gamma-phosphates in a Lambda configuration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317453     DOI: 10.1021/jm049771u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

2.  Studies of Mg2+/Ca2+ complexes of naturally occurring dinucleotides: potentiometric titrations, NMR, and molecular dynamics.

Authors:  Noa Stern; Dan Thomas Major; Hugo Emilio Gottlieb; Daniel Weizman; Alon Haim Sayer; Eliav Blum; Bilha Fischer
Journal:  J Biol Inorg Chem       Date:  2012-05-18       Impact factor: 3.358

3.  Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Authors:  Joanna Kowalska; Anna Wypijewska del Nogal; Zbigniew M Darzynkiewicz; Janina Buck; Corina Nicola; Andreas N Kuhn; Maciej Lukaszewicz; Joanna Zuberek; Malwina Strenkowska; Marcin Ziemniak; Maciej Maciejczyk; Elzbieta Bojarska; Robert E Rhoads; Edward Darzynkiewicz; Ugur Sahin; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2014-08-22       Impact factor: 16.971

4.  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

Authors:  Shay Eliahu; Alba Martín-Gil; María Jesús Perez de Lara; Jesús Pintor; Jean Camden; Gary A Weisman; Joanna Lecka; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

5.  Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor.

Authors:  Hyojin Ko; Ingrid Fricks; Andrei A Ivanov; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-04-04       Impact factor: 7.446

6.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

7.  Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

Authors:  Shir Yelovitch; Haim M Barr; Jean Camden; Gary A Weisman; Ela Shai; David Varon; Bilha Fischer
Journal:  J Med Chem       Date:  2012-08-20       Impact factor: 7.446

8.  Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.

Authors:  Andrei A Ivanov; Stefano Costanzi; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2006-10-03       Impact factor: 3.686

9.  Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis.

Authors:  D Ecke; B Fischer; G Reiser
Journal:  Br J Pharmacol       Date:  2008-09-29       Impact factor: 8.739

10.  Identification of hydrolytically stable and selective P2Y(1) receptor agonists.

Authors:  Shay E Eliahu; Jean Camden; Joanna Lecka; Gary A Weisman; Jean Sévigny; Sylvie Gélinas; Bilha Fischer
Journal:  Eur J Med Chem       Date:  2008-07-22       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.